• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Rocket Lab Announces Third Quarter 2024 Financial Results, Posts 55% Year-on-Year Growth and Guides to Record Revenue in Q4

    11/12/24 4:15:00 PM ET
    $RKLB
    Military/Government/Technical
    Industrials
    Get the next $RKLB alert in real time by email

    Rocket Lab USA, Inc. (NASDAQ:RKLB) ("Rocket Lab", "the Company", "we," "us," or "our"), a global leader in launch services and space systems, today shared the financial results for fiscal third quarter, ended September 30, 2024.

    Rocket Lab founder and CEO, Sir Peter Beck, said: "In the third quarter 2024 we once again executed against our end-to-end space strategy with successes and key achievements reached across small and medium launch, as well as space systems. Revenue grew 55% year-on-year to $105 million and we continue to see strong demand growth with our backlog at $1.05 billion. Significant achievements for the quarter included signing a launch service agreement for multiple launches on Neutron with a confidential commercial satellite constellation customer; successfully launching twelve Electron launches year-to-date, making 2024 a record year for launches with more still to come; signing $55 million in new Electron launches, further cementing Electron's position as a global launch leader; and being selected by NASA to complete a study contract for a proposal to retrieve samples from Mars and return them to Earth as part of a world-first mission. We expect to close out the year strongly with more Electron launches scheduled in November and December, alongside continued progress across Neutron and space systems, that is behind our guidance for a record $125-$135 million revenue quarter in Q4."

    Business Highlights for the Third Quarter 2024, plus updates since September 30, 2024.

    Electron:

    • Achieved a new annual launch record of 12 Electron launches to date, with more scheduled across November and December 2024. Electron is the world's third most-frequently launched rocket annually by vehicle type and remains the United States' second most-frequently launched rocket annually.
    • Signed several new Electron launch contracts in Q3 2024 with a total value of $55m, demonstrating an increased average selling price of $8.4m and showcasing a 67% pricing increase since the rocket's debut launch.
    • Successful Electron launches for three separate commercial satellite constellation operators in Q3, including two missions launched within just eight days. In addition to these, Electron's most recent mission, launched in the fourth quarter on November 5th, 2024, included an expedited turnaround of just 10 weeks between contract signing and launch.

    Neutron:

    • Signed a launch service agreement for multiple launches on Neutron with a confidential commercial satellite constellation operator that signifies the beginning of a productive collaboration that could see Neutron deploy the entire constellation.
    • Announced a federal defense contract that supports Neutron and the development of its Archimedes engine with the U.S. Air Force's Research Laboratory.
    • Doubled engine testing cadence for Archimedes over the quarter at Rocket Lab's engine test site in Mississippi, alongside strong production execution at the Company's Engine Development Complex in California which included multiple engines manufactured, assembled, and shipped for engine testing.
    • Significant progress made across Neutron's structures and infrastructure, including the completion of construction on the rocket's Assembly, Integration, and Test (A.I.T.) facility in Virginia.
    • Well-positioned to on-ramp to the U.S. Space Force's National Security Space Launch (NSSL) Lane 1 program, which began accepting proposals in November 2024 to on-ramp new launch providers to an indefinite delivery indefinite quantity (IDIQ) contract valued at $5.6 billion over a five-year period.

    Space Systems:

    • Completed production and delivery of two spacecraft on time and on budget for NASA's ESCAPADE mission to Mars.
    • Selected by NASA to complete a study contract for a proposal to retrieve samples from Mars and return them to Earth, a first-of-its-kind mission.
    • Completed two new spacecraft for Varda Space Industries to conduct the 2nd and 3rd missions to return in-space manufacturing capsules to Earth.
    • Executed on schedule against the Company's $515 million prime contract with the Space Development Agency to build 18 spacecraft for its Tranche 2 Transport Layer program.

    Fourth Quarter 2024 Guidance

    For the fourth quarter of 2024, Rocket Lab expects:

    • Revenue between $125 million and $135 million.
    • GAAP Gross Margins between 26% and 28%.
    • Non-GAAP Gross Margins between 32% and 34%.
    • GAAP Operating Expenses between $84 million and $86 million.
    • Non-GAAP Operating Expenses between $75 million and $77 million.
    • Expected Interest Expense (Income), net $1.5 million.
    • Adjusted EBITDA loss of $27 million and $29 million.
    • Basic Shares Outstanding of 501 million.

    See "Use of Non-GAAP Financial Measures" below for an explanation of our use of Non-GAAP financial measures, and the reconciliation of historical Non-GAAP measures to the comparable GAAP measures in the tables attached to this press release. We have not provided a reconciliation for the forward-looking Non-GAAP Gross Margin, Non-GAAP Operating Expenses or Adjusted EBITDA expectations for Q4 2024 described above because, without unreasonable efforts, we are unable to predict with reasonable certainty the amount and timing of adjustments that are used to calculate these non-GAAP financial measures, particularly related to stock-based compensation and its related tax effects. Stock-based compensation is currently expected to range from $12 million to $14 million in Q4 2024.

    Conference Call Information

    Rocket Lab will host a conference call for investors at 2 p.m. PT (5 p.m. ET) today to discuss these business highlights and financial results for our third quarter, to provide our outlook for the fourth quarter, and other updates.

    The live webcast and a replay of the webcast will be available on Rocket Lab's Investor Relations website: https://investors.rocketlabusa.com/events-and-presentations/events

    + About Rocket Lab

    Founded in 2006, Rocket Lab is an end-to-end space company with an established track record of mission success. We deliver reliable launch services, satellite manufacture, spacecraft components, and on-orbit management solutions that make it faster, easier, and more affordable to access space. Headquartered in Long Beach, California, Rocket Lab designs and manufactures the Electron small orbital launch vehicle, a family of spacecraft platforms, and the Company is developing the large Neutron launch vehicle for constellation deployment. Since its first orbital launch in January 2018, Rocket Lab's Electron launch vehicle has become the second most frequently launched U.S. rocket annually and has delivered 198 satellites to orbit for private and public sector organizations, enabling operations in national security, scientific research, space debris mitigation, Earth observation, climate monitoring, and communications. Rocket Lab's spacecraft platforms have been selected to support NASA missions to the Moon and Mars, as well as the first private commercial mission to Venus. Rocket Lab has three launch pads at two launch sites, including two launch pads at a private orbital launch site located in New Zealand and a third launch pad in Virginia. To learn more, visit www.rocketlabusa.com.

    + Forward Looking Statements

    This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. We intend such forward-looking statements to be covered by the safe harbor provisions for forward looking statements contained in Section 27A of the Securities Act of 1933, as amended (the "Securities Act") and Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act"). All statements contained in this press release other than statements of historical fact, including, without limitation, statements regarding our expectations of financial results for the fourth quarter of 2024, launch and space systems operations, launch schedule and window, safe and repeatable access to space, Neutron development, operational expansion and business strategy are forward-looking statements. The words "believe," "may," "will," "estimate," "potential," "continue," "anticipate," "intend," "expect," "strategy," "future," "could," "would," "project," "plan," "target," and similar expressions are intended to identify forward-looking statements, though not all forward-looking statements use these words or expressions. These statements are neither promises nor guarantees, but involve known and unknown risks, uncertainties and other important factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements, including but not limited to the factors, risks and uncertainties included in our Annual Report on Form 10-K for the fiscal year ended December 31, 2023, as such factors may be updated from time to time in our other filings with the Securities and Exchange Commission (the "SEC"), accessible on the SEC's website at www.sec.gov and the Investor Relations section of our website at www.rocketlabusa.com, which could cause our actual results to differ materially from those indicated by the forward-looking statements made in this press release. Any such forward-looking statements represent management's estimates as of the date of this press release. While we may elect to update such forward-looking statements at some point in the future, we disclaim any obligation to do so, even if subsequent events cause our views to change.

    + Use of Non-GAAP Financial Measures

    We supplement the reporting of our financial information determined under Generally Accepted Accounting Principles in the United States of America ("GAAP") with certain non-GAAP financial information. The non-GAAP financial information presented excludes certain significant items that may not be indicative of, or are unrelated to, results from our ongoing business operations. We believe that these non-GAAP measures provide investors with additional insight into the company's ongoing business performance. These non-GAAP measures should not be considered in isolation or as a substitute for the related GAAP measures, and other companies may define such measures differently. We encourage investors to review our financial statements and publicly filed reports in their entirety and not to rely on any single financial measure. Reconciliation of the non-GAAP financial information to the corresponding GAAP measures for the historical periods disclosed are included at the end of the tables in this press release. We have not provided a reconciliation for forward-looking non-GAAP financial measures because, without unreasonable efforts, we are unable to predict with reasonable certainty the amount and timing of adjustments that are used to calculate these non-GAAP financial measures, particularly related to stock-based compensation and its related tax effects. The following definitions are provided:

    + Adjusted EBITDA

    EBITDA is defined as earnings before interest, taxes, depreciation and amortization. Adjusted EBITDA further excludes items of income or loss that we characterize as unrepresentative of our ongoing operations. Such items are excluded from net income or loss to determine Adjusted EBITDA. Management believes this measure provides investors meaningful insight into results from ongoing operations.

    + Other Non-GAAP Financial Measures

    Non-GAAP gross profit, research and development, net, selling, general and administrative, operating expenses, operating loss and total other income (expense), net, further excludes items of income or loss that we characterize as unrepresentative of our ongoing operations. Such items are excluded from the applicable GAAP financial measure. Management believes these non-GAAP measures provide investors meaningful insight into results from ongoing operations.

    ROCKET LAB U.S.A., INC. AND SUBSIDIARIES

    CONSOLIDATED STATEMENTS OF OPERATIONS

    FOR THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2024 AND 2023

    (unaudited; in thousands, except share and per share data)

     

     

     

    Three Months Ended September 30,

     

    Nine Months Ended September 30,

     

     

    2024

     

    2023

     

    2024

     

    2023

    Revenues

     

    $

    104,808

     

     

    $

    67,661

     

     

    $

    303,826

     

     

    $

    184,601

     

    Cost of revenues

     

     

    76,812

     

     

     

    52,694

     

     

     

    224,494

     

     

     

    148,684

     

    Gross profit

     

     

    27,996

     

     

     

    14,967

     

     

     

    79,332

     

     

     

    35,917

     

    Operating expenses:

     

     

     

     

     

     

     

     

    Research and development, net

     

     

    47,723

     

     

     

    26,626

     

     

     

    126,139

     

     

     

    81,566

     

    Selling, general and administrative

     

     

    32,172

     

     

     

    27,200

     

     

     

    91,445

     

     

     

    84,386

     

    Total operating expenses

     

     

    79,895

     

     

     

    53,826

     

     

     

    217,584

     

     

     

    165,952

     

    Operating loss

     

     

    (51,899

    )

     

     

    (38,859

    )

     

     

    (138,252

    )

     

     

    (130,035

    )

    Other income (expense):

     

     

     

     

     

     

     

     

    Interest expense, net

     

     

    (454

    )

     

     

    (1,413

    )

     

     

    (2,176

    )

     

     

    (2,843

    )

    Loss on foreign exchange

     

     

    (490

    )

     

     

    (120

    )

     

     

    (465

    )

     

     

    (76

    )

    Other income, net

     

     

    1,848

     

     

     

    1,176

     

     

     

    3,152

     

     

     

    3,519

     

    Total other income (expense), net

     

     

    904

     

     

     

    (357

    )

     

     

    511

     

     

     

    600

     

    Loss before income taxes

     

     

    (50,995

    )

     

     

    (39,216

    )

     

     

    (137,741

    )

     

     

    (129,435

    )

    Provision for income taxes

     

     

    (944

    )

     

     

    (1,352

    )

     

     

    (89

    )

     

     

    (2,639

    )

    Net loss

     

    $

    (51,939

    )

     

    $

    (40,568

    )

     

    $

    (137,830

    )

     

    $

    (132,074

    )

    Net loss per share attributable to Rocket Lab USA, Inc.:

     

     

     

     

     

     

     

     

    Basic and diluted

     

    $

    (0.10

    )

     

    $

    (0.08

    )

     

    $

    (0.28

    )

     

    $

    (0.28

    )

    Weighted-average common shares outstanding:

     

     

     

     

     

     

     

     

    Basic and diluted

     

     

    497,701,715

     

     

     

    484,034,071

     

     

     

    493,976,025

     

     

     

    480,018,578

     

    ROCKET LAB U.S.A., INC. AND SUBSIDIARIES

    CONSOLIDATED BALANCE SHEETS

    AS OF SEPTEMBER 30, 2024 AND DECEMBER 31, 2023

    (unaudited; in thousands, except share and per share data)

     

     

     

    September 30,

    2024

     

    December 31,

     

     

    (unaudited)

     

    2023

    Assets

     

     

     

     

    Current assets:

     

     

     

     

    Cash and cash equivalents

     

    $

    292,470

     

     

    $

    162,518

     

    Marketable securities, current

     

     

    149,919

     

     

     

    82,255

     

    Accounts receivable, net

     

     

    22,148

     

     

     

    35,176

     

    Contract assets

     

     

    49,461

     

     

     

    12,951

     

    Inventories

     

     

    114,435

     

     

     

    107,857

     

    Prepaids and other current assets

     

     

    67,066

     

     

     

    66,949

     

    Assets held for sale

     

     

    —

     

     

     

    9,016

     

    Total current assets

     

     

    695,499

     

     

     

    476,722

     

    Non-current assets:

     

     

     

     

    Property, plant and equipment, net

     

     

    170,983

     

     

     

    145,409

     

    Intangible assets, net

     

     

    61,582

     

     

     

    68,094

     

    Goodwill

     

     

    71,020

     

     

     

    71,020

     

    Right-of-use assets - operating leases

     

     

    53,985

     

     

     

    59,401

     

    Right-of-use assets - finance leases

     

     

    14,518

     

     

     

    14,987

     

    Marketable securities, non-current

     

     

    61,292

     

     

     

    79,247

     

    Restricted cash

     

     

    4,322

     

     

     

    3,916

     

    Deferred income tax assets, net

     

     

    1,419

     

     

     

    3,501

     

    Other non-current assets

     

     

    18,409

     

     

     

    18,914

     

    Total assets

     

    $

    1,153,029

     

     

    $

    941,211

     

    Liabilities and Stockholders' Equity

     

     

     

     

    Current liabilities:

     

     

     

     

    Trade payables

     

    $

    42,434

     

     

    $

    29,303

     

    Accrued expenses

     

     

    8,063

     

     

     

    5,590

     

    Employee benefits payable

     

     

    19,335

     

     

     

    16,342

     

    Contract liabilities

     

     

    167,129

     

     

     

    139,338

     

    Current installments of long-term borrowings

     

     

    11,758

     

     

     

    17,764

     

    Other current liabilities

     

     

    20,480

     

     

     

    15,036

     

    Total current liabilities

     

     

    269,199

     

     

     

    223,373

     

    Non-current liabilities:

     

     

     

     

    Convertible senior notes, net

     

     

    344,865

     

     

     

    —

     

    Long-term borrowings, net, excluding current installments

     

     

    46,915

     

     

     

    87,587

     

    Non-current operating lease liabilities

     

     

    51,906

     

     

     

    56,099

     

    Non-current finance lease liabilities

     

     

    15,042

     

     

     

    15,238

     

    Deferred tax liabilities

     

     

    726

     

     

     

    426

     

    Other non-current liabilities

     

     

    4,541

     

     

     

    3,944

     

    Total liabilities

     

     

    733,194

     

     

     

    386,667

     

    COMMITMENTS AND CONTINGENCIES

     

     

     

     

    Stockholders' equity:

     

     

     

     

    Common stock, $0.0001 par value; authorized shares: 2,500,000,000; issued and outstanding shares: 499,700,976 and 488,923,055 at September 30, 2024 and December 31, 2023, respectively

     

     

    50

     

     

     

    49

     

    Additional paid-in capital

     

     

    1,178,828

     

     

     

    1,176,484

     

    Accumulated deficit

     

     

    (761,356

    )

     

     

    (623,526

    )

    Accumulated other comprehensive income

     

     

    2,313

     

     

     

    1,537

     

    Total stockholders' equity

     

     

    419,835

     

     

     

    554,544

     

    Total liabilities and stockholders' equity

     

    $

    1,153,029

     

     

    $

    941,211

     

    ROCKET LAB U.S.A., INC. AND SUBSIDIARIES

    CONSOLIDATED STATEMENTS OF CASH FLOWS

    FOR THE NINE MONTHS ENDED SEPTEMBER 30, 2024 AND 2023

    (unaudited; in thousands)

     

     

     

    For the Nine Months Ended

    September 30,

     

     

    2024

     

    2023

    CASH FLOWS FROM OPERATING ACTIVITIES:

     

     

     

     

    Net loss

     

    $

    (137,830

    )

     

    $

    (132,074

    )

    Adjustments to reconcile net loss to net cash used in operating activities:

     

     

     

     

    Depreciation and amortization

     

     

    24,516

     

     

     

    21,577

     

    Stock-based compensation expense

     

     

    39,944

     

     

     

    43,398

     

    (Gain) loss on disposal of assets

     

     

    (2,356

    )

     

     

    240

     

    Loss on extinguishment of long-term debt

     

     

    1,330

     

     

     

    —

     

    Amortization of debt issuance costs and discount

     

     

    2,272

     

     

     

    2,166

     

    Noncash lease expense

     

     

    4,437

     

     

     

    4,062

     

    Change in the fair value of contingent consideration

     

     

    (218

    )

     

     

    1,138

     

    Accretion of marketable securities purchased at a discount

     

     

    (2,272

    )

     

     

    (3,399

    )

    Deferred income taxes

     

     

    2,310

     

     

     

    644

     

    Changes in operating assets and liabilities:

     

     

     

     

    Accounts receivable, net

     

     

    12,928

     

     

     

    13,798

     

    Contract assets

     

     

    (36,510

    )

     

     

    (3,592

    )

    Inventories

     

     

    (7,118

    )

     

     

    (10,933

    )

    Prepaids and other current assets

     

     

    1,951

     

     

     

    (15,819

    )

    Other non-current assets

     

     

    544

     

     

     

    (10,712

    )

    Trade payables

     

     

    13,853

     

     

     

    12,026

     

    Accrued expenses

     

     

    2,980

     

     

     

    (2,187

    )

    Employee benefits payables

     

     

    3,525

     

     

     

    5,285

     

    Contract liabilities

     

     

    27,791

     

     

     

    25,450

     

    Other current liabilities

     

     

    4,088

     

     

     

    (4,632

    )

    Non-current lease liabilities

     

     

    (4,321

    )

     

     

    (3,316

    )

    Other non-current liabilities

     

     

    1,653

     

     

     

    230

     

    Net cash used in operating activities

     

     

    (46,503

    )

     

     

    (56,650

    )

    CASH FLOWS FROM INVESTING ACTIVITIES:

     

     

     

     

    Purchases of property, equipment and software

     

     

    (45,539

    )

     

     

    (44,293

    )

    Proceeds on disposal of assets, net

     

     

    11,756

     

     

     

    —

     

    Cash paid for asset acquisition

     

     

    —

     

     

     

    (16,934

    )

    Purchases of marketable securities

     

     

    (149,548

    )

     

     

    (207,266

    )

    Maturities of marketable securities

     

     

    102,930

     

     

     

    219,340

     

    Net cash used in investing activities

     

     

    (80,401

    )

     

     

    (49,153

    )

    CASH FLOWS FROM FINANCING ACTIVITIES:

     

     

     

     

    Proceeds from the exercise of stock options

     

     

    2,074

     

     

     

    2,293

     

    Proceeds from Employee Stock Purchase Plan

     

     

    4,098

     

     

     

    3,780

     

    Proceeds from sale of employees restricted stock units to cover taxes

     

     

    14,991

     

     

     

    12,390

     

    Minimum tax withholding paid on behalf of employees for restricted stock units

     

     

    (15,169

    )

     

     

    (12,352

    )

    Payment of contingent consideration

     

     

    —

     

     

     

    (1,000

    )

    Purchase of capped calls related to issuance of convertible senior notes

     

     

    (43,168

    )

     

     

    —

     

    Proceeds from issuance of convertible senior notes

     

     

    355,000

     

     

     

    —

     

    Repayments on Trinity Loan Agreement

     

     

    (48,853

    )

     

     

    —

     

    Payment of debt issuance costs

     

     

    (12,205

    )

     

     

    —

     

    Finance lease principal payments

     

     

    (269

    )

     

     

    (248

    )

    Net cash provided by financing activities

     

     

    256,499

     

     

     

    4,863

     

    Effect of exchange rate changes on cash and cash equivalents

     

     

    763

     

     

     

    (439

    )

    Net increase (decrease) in cash and cash equivalents and restricted cash

     

     

    130,358

     

     

     

    (101,379

    )

    Cash and cash equivalents, and restricted cash, beginning of period

     

     

    166,434

     

     

     

    245,871

     

    Cash and cash equivalents, and restricted cash, end of period

     

    $

    296,792

     

     

    $

    144,492

     

    ROCKET LAB U.S.A., INC. AND SUBSIDIARIES

    RECONCILIATION OF NON-GAAP FINANCIAL MEASURES

    FOR THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2024 AND 2023

    (unaudited; in thousands)

     

    The tables provided below reconcile the non-GAAP financial measures Adjusted EBITDA, Non-GAAP gross profit, Non-GAAP research and development, net, Non-GAAP selling, general and administrative, Non-GAAP operating expenses, Non-GAAP operating loss and Non-GAAP total other income (expense), net with the most directly comparable GAAP financial measures. See above for additional information on the use of these non-GAAP financial measures.

     

     

     

    Three Months Ended

    September 30,

     

    Nine Months Ended

    September 30,

     

     

    2024

     

    2023

     

    2024

     

    2023

    NET LOSS

     

    $

    (51,939

    )

     

    $

    (40,568

    )

     

    $

    (137,830

    )

     

    $

    (132,074

    )

    Depreciation

     

     

    4,793

     

     

     

    4,237

     

     

     

    14,513

     

     

     

    11,463

     

    Amortization

     

     

    3,302

     

     

     

    3,555

     

     

     

    10,003

     

     

     

    10,114

     

    Stock-based compensation expense

     

     

    12,896

     

     

     

    14,098

     

     

     

    39,944

     

     

     

    43,398

     

    Transaction costs

     

     

    23

     

     

     

    142

     

     

     

    407

     

     

     

    311

     

    Interest expense, net

     

     

    454

     

     

     

    1,413

     

     

     

    2,176

     

     

     

    2,843

     

    Change in fair value of contingent consideration

     

     

    —

     

     

     

    (462

    )

     

     

    (218

    )

     

     

    1,138

     

    Performance reserve escrow

     

     

    —

     

     

     

    1,800

     

     

     

    —

     

     

     

    5,426

     

    Provision for income taxes

     

     

    944

     

     

     

    1,352

     

     

     

    89

     

     

     

    2,639

     

    Loss on foreign exchange

     

     

    490

     

     

     

    120

     

     

     

    465

     

     

     

    76

     

    Accretion of marketable securities purchased at a discount

     

     

    (666

    )

     

     

    (1,447

    )

     

     

    (2,272

    )

     

     

    (3,601

    )

    (Gain) loss on disposal of assets

     

     

    (1,164

    )

     

     

    213

     

     

     

    (2,356

    )

     

     

    240

     

    Employee retention credit

     

     

    —

     

     

     

    —

     

     

     

    —

     

     

     

    (3,841

    )

    Loss on extinguishment of debt

     

     

    —

     

     

     

    —

     

     

     

    1,330

     

     

     

    —

     

    ADJUSTED EBITDA

     

    $

    (30,867

    )

     

    $

    (15,547

    )

     

    $

    (73,749

    )

     

    $

    (61,868

    )

     

     

    Three Months Ended

    September 30,

     

    Nine Months Ended

    September 30,

     

     

    2024

     

    2023

     

    2024

     

    2023

    GAAP Gross profit

     

    $

    27,996

     

     

    $

    14,967

     

     

    $

    79,332

     

     

    $

    35,917

     

    Stock-based compensation

     

     

    3,029

     

     

     

    3,182

     

     

     

    10,205

     

     

     

    10,325

     

    Amortization of purchased intangibles and favorable lease

     

     

    1,763

     

     

     

    1,710

     

     

     

    5,247

     

     

     

    5,129

     

    Performance reserve escrow

     

     

    —

     

     

     

    76

     

     

     

    —

     

     

     

    209

     

    Employee retention credit

     

     

    —

     

     

     

    —

     

     

     

    —

     

     

     

    (2,130

    )

    Non-GAAP Gross profit

     

    $

    32,788

     

     

    $

    19,935

     

     

    $

    94,784

     

     

    $

    49,450

     

    Non-GAAP Gross margin

     

     

    31.3

    %

     

     

    29.5

    %

     

     

    31.2

    %

     

     

    26.8

    %

     

     

     

     

     

     

     

     

     

    GAAP Research and development, net

     

    $

    47,723

     

     

    $

    26,626

     

     

    $

    126,139

     

     

    $

    81,566

     

    Stock-based compensation

     

     

    (4,626

    )

     

     

    (6,219

    )

     

     

    (13,660

    )

     

     

    (17,893

    )

    Amortization of purchased intangibles and favorable lease

     

     

    (302

    )

     

     

    (315

    )

     

     

    (686

    )

     

     

    (333

    )

    Employee retention credit

     

     

    —

     

     

     

    —

     

     

     

    —

     

     

     

    631

     

    Non-GAAP Research and development, net

     

    $

    42,795

     

     

    $

    20,092

     

     

    $

    111,793

     

     

    $

    63,971

     

     

     

     

     

     

     

     

     

     

    GAAP Selling, general and administrative

     

    $

    32,172

     

     

    $

    27,200

     

     

    $

    91,445

     

     

    $

    84,386

     

    Stock-based compensation

     

     

    (5,241

    )

     

     

    (4,697

    )

     

     

    (16,079

    )

     

     

    (15,180

    )

    Amortization of purchased intangibles and favorable lease

     

     

    (960

    )

     

     

    (1,378

    )

     

     

    (3,274

    )

     

     

    (4,207

    )

    Transaction costs

     

     

    (23

    )

     

     

    (142

    )

     

     

    (407

    )

     

     

    (311

    )

    Performance reserve escrow

     

     

    —

     

     

     

    (1,724

    )

     

     

    —

     

     

     

    (5,217

    )

    Change in fair value of contingent consideration

     

     

    —

     

     

     

    462

     

     

     

    218

     

     

     

    (1,138

    )

    Employee retention credit

     

     

    —

     

     

     

    —

     

     

     

    —

     

     

     

    1,080

     

    Non-GAAP Selling, general and administrative

     

    $

    25,948

     

     

    $

    19,721

     

     

    $

    71,903

     

     

    $

    59,413

     

     

     

     

     

     

     

     

     

     

    GAAP Operating expenses

     

    $

    79,895

     

     

    $

    53,826

     

     

    $

    217,584

     

     

    $

    165,952

     

    Stock-based compensation

     

     

    (9,867

    )

     

     

    (10,916

    )

     

     

    (29,739

    )

     

     

    (33,073

    )

    Amortization of purchased intangibles and favorable lease

     

     

    (1,262

    )

     

     

    (1,693

    )

     

     

    (3,960

    )

     

     

    (4,540

    )

    Transaction costs

     

     

    (23

    )

     

     

    (142

    )

     

     

    (407

    )

     

     

    (311

    )

    Performance reserve escrow

     

     

    —

     

     

     

    (1,724

    )

     

     

    —

     

     

     

    (5,217

    )

    Change in fair value of contingent consideration

     

     

    —

     

     

     

    462

     

     

     

    218

     

     

     

    (1,138

    )

    Employee retention credit

     

     

    —

     

     

     

    —

     

     

     

    —

     

     

     

    1,711

     

    Non-GAAP Operating expenses

     

    $

    68,743

     

     

    $

    39,813

     

     

    $

    183,696

     

     

    $

    123,384

     

     

     

     

     

     

     

     

     

     

    GAAP Operating loss

     

    $

    (51,899

    )

     

    $

    (38,859

    )

     

    $

    (138,252

    )

     

    $

    (130,035

    )

    Total non-GAAP adjustments

     

     

    15,944

     

     

     

    18,981

     

     

     

    49,340

     

     

     

    56,101

     

    Non-GAAP Operating loss

     

    $

    (35,955

    )

     

    $

    (19,878

    )

     

    $

    (88,912

    )

     

    $

    (73,934

    )

     

     

     

     

     

     

     

     

     

    GAAP Total other income (expense), net

     

    $

    904

     

     

    $

    (357

    )

     

    $

    511

     

     

    $

    600

     

    Loss on foreign exchange

     

     

    490

     

     

     

    120

     

     

     

    465

     

     

     

    76

     

    (Gain) loss on disposal of assets

     

     

    (1,164

    )

     

     

    213

     

     

     

    (2,356

    )

     

     

    240

     

    Loss on extinguishment of debt

     

     

    —

     

     

     

    —

     

     

     

    1,330

     

     

     

    —

     

    Non-GAAP Total other income (expense), net

     

    $

    230

     

     

    $

    (24

    )

     

    $

    (50

    )

     

    $

    916

     

     

    View source version on businesswire.com: https://www.businesswire.com/news/home/20241112640424/en/

    Get the next $RKLB alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $RKLB

    DatePrice TargetRatingAnalyst
    4/25/2025$28.00Buy
    Needham
    9/12/2024Mkt Perform
    JMP Securities
    7/15/2024$8.00 → $6.00Overweight → Equal-Weight
    Morgan Stanley
    6/26/2024Neutral
    BTIG Research
    6/11/2024$4.50Neutral
    Goldman
    2/12/2024$6.00Buy
    Citigroup
    1/17/2024$8.00Overweight
    KeyBanc Capital Markets
    10/26/2023$6.00Overweight
    Cantor Fitzgerald
    More analyst ratings

    $RKLB
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Officer Kampani Arjun sold $158,152 worth of shares (5,277 units at $29.97), decreasing direct ownership by 0.92% to 569,606 units (SEC Form 4)

      4 - Rocket Lab Corp (0001819994) (Issuer)

      5/30/25 6:06:28 PM ET
      $RKLB
      Military/Government/Technical
      Industrials
    • Chief Operations Officer Klein Frank sold $76,999 worth of shares (2,569 units at $29.97), decreasing direct ownership by 0.18% to 1,415,075 units (SEC Form 4)

      4 - Rocket Lab Corp (0001819994) (Issuer)

      5/30/25 6:01:49 PM ET
      $RKLB
      Military/Government/Technical
      Industrials
    • Chief Operations Officer Klein Frank sold $846,607 worth of shares (46,388 units at $18.25), decreasing direct ownership by 3% to 1,417,644 units (SEC Form 4)

      4 - Rocket Lab USA, Inc. (0001819994) (Issuer)

      3/18/25 8:41:08 PM ET
      $RKLB
      Military/Government/Technical
      Industrials

    $RKLB
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Needham initiated coverage on Rocket Lab USA with a new price target

      Needham initiated coverage of Rocket Lab USA with a rating of Buy and set a new price target of $28.00

      4/25/25 8:32:44 AM ET
      $RKLB
      Military/Government/Technical
      Industrials
    • JMP Securities initiated coverage on Rocket Lab USA

      JMP Securities initiated coverage of Rocket Lab USA with a rating of Mkt Perform

      9/12/24 9:09:33 AM ET
      $RKLB
      Military/Government/Technical
      Industrials
    • Rocket Lab USA downgraded by Morgan Stanley with a new price target

      Morgan Stanley downgraded Rocket Lab USA from Overweight to Equal-Weight and set a new price target of $6.00 from $8.00 previously

      7/15/24 7:47:38 AM ET
      $RKLB
      Military/Government/Technical
      Industrials

    $RKLB
    SEC Filings

    See more
    • SEC Form 144 filed by Rocket Lab USA Inc.

      144 - Rocket Lab Corp (0001819994) (Subject)

      5/30/25 7:41:36 PM ET
      $RKLB
      Military/Government/Technical
      Industrials
    • SEC Form 144 filed by Rocket Lab USA Inc.

      144 - Rocket Lab Corp (0001819994) (Subject)

      5/30/25 7:39:00 PM ET
      $RKLB
      Military/Government/Technical
      Industrials
    • SEC Form 424B5 filed by Rocket Lab USA Inc.

      424B5 - Rocket Lab Corp (0001819994) (Filer)

      5/30/25 8:03:35 AM ET
      $RKLB
      Military/Government/Technical
      Industrials

    $RKLB
    Financials

    Live finance-specific insights

    See more
    • Rocket Lab Enters Payload Market with Agreement to Acquire Geost, Positioning Itself as Disruptive Prime to U.S. National Security

      The strategic acquisition would create an entirely new category for Rocket Lab, positioning the Company as a disruptor for national security space. Rocket Lab Corporation (NASDAQ:RKLB) ("Rocket Lab" or the "Company"), a global leader in launch services and space systems, today announced the signing of a definitive agreement to acquire the parent holding company of Geost, LLC ("Geost"), a Tucson, Arizona-based electro-optical and infrared (EO/IR) payload development and manufacturing company and provider to high-priority national security satellites, from Lightridge Solutions, a portfolio company of ATL Partners, for $275 million in a mix of $125 million of cash and $150 million in private

      5/27/25 4:15:00 PM ET
      $RKLB
      Military/Government/Technical
      Industrials
    • Rocket Lab Announces First Quarter 2025 Financial Results, Posting Quarterly Revenue of $123m Representing 32% Year-on-Year Growth

      Rocket Lab USA, Inc. (NASDAQ:RKLB) ("Rocket Lab," "the Company," "we," "us," or "our"), a global leader in launch services and space systems, today shared the financial results for fiscal first quarter ended March 31, 2025. Rocket Lab founder and CEO Sir Peter Beck said: "Rocket Lab has delivered a strong first quarter performance, with wins across our launch and space systems divisions reflected in our near-record $123 million revenue – at the top end of our guidance and a 32% increase year-on-year compared to Q1 2024. We also remain confident in our ability to execute and deliver on what's set to be another strong quarter, with our Q2 2025 revenue guidance in the $130m-$140 million range

      5/8/25 4:15:00 PM ET
      $RKLB
      Military/Government/Technical
      Industrials
    • Rocket Lab Announces Date of First Quarter 2025 Financial Results

      Rocket Lab USA, Inc. ("Rocket Lab" or "the Company"), a global leader in launch services and space systems, today announced that it will release its financial results for the first quarter 2025 following the close of the U.S. markets on Thursday, May 8, 2025. Rocket Lab will host a corresponding conference call at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time). A live webcast and replay of the conference call will be available on the Company's Investor Relations website at www.rocketlabusa.com/investors. About Rocket Lab Founded in 2006, Rocket Lab is an end-to-end space company with an established track record of mission success. We deliver reliable launch services, satellite manufactu

      4/3/25 4:30:00 PM ET
      $RKLB
      Military/Government/Technical
      Industrials

    $RKLB
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13D/A filed by Rocket Lab USA Inc.

      SC 13D/A - Rocket Lab USA, Inc. (0001819994) (Subject)

      12/5/24 9:49:25 PM ET
      $RKLB
      Military/Government/Technical
      Industrials
    • Amendment: SEC Form SC 13D/A filed by Rocket Lab USA Inc.

      SC 13D/A - Rocket Lab USA, Inc. (0001819994) (Subject)

      12/3/24 9:39:57 PM ET
      $RKLB
      Military/Government/Technical
      Industrials
    • Amendment: SEC Form SC 13G/A filed by Rocket Lab USA Inc.

      SC 13G/A - Rocket Lab USA, Inc. (0001819994) (Subject)

      11/12/24 4:45:55 PM ET
      $RKLB
      Military/Government/Technical
      Industrials

    $RKLB
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • ATL Partners Announces Sale of Geost to Rocket Lab and Launches New Defense Electronics Platform, Trident Solutions

      ATL Partners ("ATL"), a sector-focused private equity firm, today announced the sale of Geost, LLC ("Geost"), a subsidiary of its portfolio company LightRidge Solutions, to Rocket Lab USA, Inc. (NASDAQ:RKLB), a leading space systems and launch services provider. This transaction represents a successful exit for ATL, which acquired Geost in 2021 and, in partnership with management, scaled the business into a market leader in electro-optical and infrared (EO/IR) sensing technologies supporting high-priority national security space missions. With more than 20 years of flight heritage across classified and unclassified missions, Geost delivers advanced EO/IR sensor systems for missile warning

      5/27/25 4:20:00 PM ET
      $RKLB
      Military/Government/Technical
      Industrials
    • Rocket Lab Enters Payload Market with Agreement to Acquire Geost, Positioning Itself as Disruptive Prime to U.S. National Security

      The strategic acquisition would create an entirely new category for Rocket Lab, positioning the Company as a disruptor for national security space. Rocket Lab Corporation (NASDAQ:RKLB) ("Rocket Lab" or the "Company"), a global leader in launch services and space systems, today announced the signing of a definitive agreement to acquire the parent holding company of Geost, LLC ("Geost"), a Tucson, Arizona-based electro-optical and infrared (EO/IR) payload development and manufacturing company and provider to high-priority national security satellites, from Lightridge Solutions, a portfolio company of ATL Partners, for $275 million in a mix of $125 million of cash and $150 million in private

      5/27/25 4:15:00 PM ET
      $RKLB
      Military/Government/Technical
      Industrials
    • BlackSky and Rocket Lab Establish Launch Window for Second Gen-3 Satellite

      "Full Stream Ahead" mission to add very high-resolution 35-centimeter imaging capability to BlackSky's high-cadence, low-latency data and AI-enabled analytics offerings BlackSky Technology Inc. (NYSE: BKSY) and Rocket Lab USA, Inc. (NASDAQ:RKLB) have established a launch window opening May 27 for the second Gen-3 satellite. The launch, named "Full Stream Ahead," will add very high-resolution 35-centimeter imaging capability to BlackSky's high-cadence, low-latency data and AI-enabled analytics offerings. "Each successive Gen-3 launch represents a major step forward for our global defense and intelligence customer base with the prospect of new mission applications that will be enabled by co

      5/22/25 8:30:00 AM ET
      $BKSY
      $RKLB
      Radio And Television Broadcasting And Communications Equipment
      Technology
      Military/Government/Technical
      Industrials

    $RKLB
    Leadership Updates

    Live Leadership Updates

    See more
    • Rocket Lab Awarded New HASTE Launch Contract for the DOD by Kratos

      Rocket Lab USA, Inc. (NASDAQ:RKLB) ("Rocket Lab" or "the Company"), a global leader in launch services and space systems, today announced it has been selected by Kratos to launch a full-scale hypersonic test flight for the Department of Defense (DOD) under the Multi-Service Advanced Capability Hypersonic Test Bed (MACH-TB) 2.0 program. The mission will launch on Rocket Lab's HASTE rocket from Rocket Lab Launch Complex 2 on Wallops Island, Virginia no earlier than Q1, 2026. The launch agreement is the first full-scale flight test to be awarded by Kratos under the MACH-TB 2.0 contract, a $1.45 billion program designed to rapidly expand the number and frequency of opportunities to test hypers

      4/23/25 4:30:00 PM ET
      $RKLB
      Military/Government/Technical
      Industrials
    • Rocket Lab Appoints Chief Operations Officer to Support Company Growth

      Rocket Lab USA, Inc. (NASDAQ:RKLB) ("Rocket Lab" or "the Company"), a global leader in launch services and space systems, today announced the appointment of Frank Klein as its new Chief Operations Officer (COO), effective September 16th, 2024. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240910807125/en/Rocket Lab's new Chief Operations Officer, Frank Klein. (Photo: Business Wire) Frank Klein joins Rocket Lab with more than 30 years of international manufacturing experience and leadership in the automotive industry. At Rocket Lab, Mr. Klein will lead the Company's efforts to scale manufacturing of spacecraft, launch vehicles, a

      9/10/24 7:00:00 AM ET
      $RKLB
      Military/Government/Technical
      Industrials
    • Former Lockheed Martin Chief Financial Officer Joins Rocket Lab Board of Directors

      Rocket Lab USA, Inc. (NASDAQ:RKLB) ("Rocket Lab" or "the Company"), a global leader in launch services and space systems, today announced that Kenneth (Ken) Possenriede has been appointed to the Company's Board of Directors. A seasoned executive with strong business and financial acumen, Mr. Possenriede joins Rocket Lab after a 35-year career at Lockheed Martin Corporation in financial leadership positions, including serving as Chief Financial Officer (CFO). "Ken's deep aerospace and defense industry experience, combined with accomplished financial leadership, adds even more horsepower to Rocket Lab's already impressive board line-up," said Rocket Lab's founder and Chief Executive Offic

      8/22/24 4:30:00 PM ET
      $RKLB
      Military/Government/Technical
      Industrials